Melanin is the major cellular component commonly observed in bacteria, fungi, plants, and animals responsible for skin color[@b1]. It presents as a complex, heterogeneous polyphenol-like biopolymer structure and colors vary from yellow to black[@b2], secreted by melanocyte cells in the basal layer of the dermis[@b3]. Normal melanin pigmentation is able to shield from UV radiation, inhibit photocarcinogenesis and affect the synthesis of vitamin D3[@b4]. In contrast, the abnormal pigmentation, such as senile lentigines, freckles, melasma, and other forms of melanin hyperpigmentation, causes serious esthetic problems[@b5][@b6]. The oxidative reactions of the tyrosine catalyzed by tyrosinase mainly contributes to the melanin biosynthesis[@b7].

As a binuclear copper enzyme, tyrosinase (monophenol monooxygenase EC 1.14.14.1) catalyzes two distinct reactions of melanin biosynthesis. It catalyzes phenols to catechols and further oxidizes catechols to quinones[@b8]. The tyrosinase contains two copper ions, coordinating with histidine residues in the active site. The two copper ions are critical for the catalytic activities of this enzyme[@b9] and exist in different tyrosinases regardless of their source[@b10][@b11]. Since tyrosinase-catalyzed reaction is highly associated with local hyperpigmentaiton such as ephelide, melasma, and lentigo[@b5], discovering of tyrosinase inhibitors are of great importance in cosmetic and medicinal products for the prevention of pigmentation disorders[@b12]. Recently, significant efforts have been made to search for the tyrosinase inhibitors with copper chelator ability as whitening and anti-hyperpigment agents[@b13][@b14][@b15][@b16][@b17][@b18], and several tyrosinase inhibitors have also been used as depigmentation ingredients of medical products[@b19][@b20][@b21][@b22].

Many tyrosinase inhibitors, such as hydroquinone[@b23][@b24][@b25][@b26], kojic acid[@b20], azelaic acid[@b27][@b28], electron-rich phenols[@b29], and arbutin have been tested in pharmaceuticals and cosmetics for their capability of preventing overproduction of melanin[@b30][@b31]. Meanwhile, their structure-activity relationship (SAR) analysis have been widely discussed[@b32] ([Supplementary Table S1](#s1){ref-type="supplementary-material"}). Hydroquinone is one of the most frequently prescribed ingredients among the conventional skin-whitening agents. However, hydroquinone causes skin irritation[@b33], and it is thought to be mutagenic to mammalian cells[@b34] and cytotoxic to melanocytes. This leads to the use of kojic acid and arbutin as alternative agents, but these agents show poor efficacy *in vivo*. In addition, due to their adverse side effects, low formulation stability, and poor skin penetration[@b35], their use is still limited. The Japanese officials also spurred to ban the use of kojic acid in skin treatment due to its carcinogenicity[@b36]. Thus, it is in great need of developing new tyrosinase inhibitors from different sources. In this regard, the natural products have been extensively utilized in the cosmetics industry[@b37][@b38][@b39] because of lower adverse side effects and high safety.

Recently, the extracts and isolated compounds of a number of natural sources in particular botanical sources were well characterized with anti-tyrosinase activities[@b40][@b41][@b42][@b43][@b44][@b45][@b46][@b47][@b48][@b49][@b50][@b51] and have been accepted as popular skin lightening agents[@b52][@b53][@b54][@b55][@b56]. In this study, we have screened 78 different medicine herbal plants and identified that rhizome of *Gastrodia elata* is of great potency for tyrosinase inhibition. The rhizome of *Gastrodia elata* has been applied in for the treatment of dizziness, headaches, vertigo, and convulsive illnesses[@b57]. The studies of how *Gastrodia elata* prevents the neuronal damage have been performed as well[@b58][@b59][@b60][@b61][@b62][@b63], but its efficacy on tyrosinase inhibition and melanin biosynthesis has not been thoroughly investigated. Thus, here we aim to isolate the functional components from the rhizome of *Gastrodia elata* and investigate its inhibitory effect on the mushroom tyrosinase and human melanogenesis. The natural compounds, **T1** and **T2** extracted from *Gastrodia elata* and their derivatives **T3--T5**, exert profound mushroom tyrosinase inhibitory abilities. The bioactive natural product **T1**, bis(4-hydroxybenzyl)sulfide, with the most striking inhibitory potency against tyrosinase, was chosen as the target compound to characterize its biological effects in tyrosinase inhibition, cell viability, *in vitro and in vivo* melanin biosynthesis, and acute oral toxicity in mice.

Methods
=======

Mushroom tyrosinase inhibition assay and IC~50~ determination
-------------------------------------------------------------

Tyrosinase inhibition activity was evaluated *by* using L-tyrosine as the substrate *in vitro* according to the previous method[@b64]. **T1** and **T2** chemicals were obtained from our previous neuroprotective research[@b57]. **T3**, **T4** and **T5** chemicals were purchased from ACROS Organics (Geel, Belgium). **T1** and its analogous compounds (**T2--T5**) were prepared (dissolved in 1% DMSO) into distinct concentration inhibitor solutions. Briefly, 80 μl of 67 mM potassium phosphate buffer (NaH~2~PO~4~-Na~2~HPO~4~, pH6.8), 25 μl of desired concentration of inhibitor solution and 125 μl of 5 mM L-tyrosine were mixed and added into each well of a 96-well Elisa plate, incubated at 25°C for 5 minutes. After that 20 μl of 1250 U/ml mushroom tyrosinase solution was added into each well to a final volume 250 μl and incubated at 25°C for another 5 minutes. Furthermore, the amount of dopachrome produced was determined against blank by a spectrophotometer (Varian cary-50 Bio UV-Visible spectrophotometer) at 475 nm for 10 minutes. We recorded dopachrome accumulation in each 10 seconds for 10 minutes. In addition, kojic acid and β-arbutin were used as the positive control at the same concentrations and conditions to those of the tested inhibitors. The reaction correlating with the amount of dopachrome produced was determined by the previously described method[@b64]. The tyrosinase activity is calculated with the following equation: where *S* denotes the OD~475~ absorbance of test compound, *B* is OD~475~ absorbance of the blank, and *C* represents the OD~475~ absorbance of control. The dose-dependent inhibition experiments were performed in triplicate to determine the IC~50~ of the test compounds.

Cell viability and Melanin quantification assay
-----------------------------------------------

Normal human epidermal melanocytes (Cascade Biologics^TM^ (Portland, OR)) were cultured in HMGS (Cascade Biologics) supplemented Medium 254. For experiments, confluent cells were trypsinized and suspended in Melanocyte Growth Medium M2 at 2 × 10^5^ cells/ml. Then the cells were placed in 96-well plates (2 × 10^4^ cells/well) for cell viability assay and 24-well plates (1 × 10^5^/well) for melanin content assay. After 24 hours, the cells were respectively treated with α-arbutin (50 μM), β-arbutin (50 μM), kojic acid (50 μM), and **T1** (5 μM and 50 μM) at 37°C and incubated for 72 hours. Cell viabilities were determined by MTT method[@b15][@b65][@b66][@b67]. From measurement of melanin contents, 1N hot NaOH (70°C) was used to and dissolved the melanocyte pellets for 1 hour and further centrifuged at 10,000 × *g* for 10 min. The microplate reader (Molecular Devices Spectra Max M2) was employed to determine the optical density (OD~405~) of each supernatant.

Zebrafish in vivo assay
-----------------------

Zebrafish *in vivo* assay was performed according to the previous method[@b68]. The collected synchronized zebrafish embryos were arrayed by pipette into a 96-well plate, three embryos per well with 200 μl embryo medium. The prepared inhibitor solutions (in 1% DMSO) were added to the embryo medium from 9 to 57 hpf (hours post fertilization, total 48 h exposure). The positive controls were 0.1, 1, and 10 mM arbutin and 10, 25, 40, and 50 μM kojic acid. Stereomicroscope was employed for observing the effects on the pigmentation of zebrafish. Phenotype-based evaluation of the body pigmentation was performed at 57 hpf. Embryos were deteriorated by forceps, anesthetized in tricaine methanesulfonate solution (Sigma-Aldrich), mounted in 1% methyl cellulose on a depression slide (Aquatic Eco-Systems, Apopka, FL, USA) and photographed under the stereomicroscope Z16 (Leica Microsystems, Ernst-Leitz-Strasse, Germany) for observation. Images capturing and pixel measurement analysis were carried out by our same method described previously[@b69]. All the experimental protocols were reviewed and approved by National Sun Yat-sen University Animal Care and Use Committee (Approval 10117). We followed the Guiding Principles in the Care and Use of Animals of the American Physiology Society during zebrafish maintenance and experimentation.

Acute oral toxicity study in mice
---------------------------------

An acute oral toxicity study was performed to evaluate the toxicity of **T1** in ICR male mice (Strain: Cr1: CD1 (IICR); Source: BioLASCO Taiwan C0., Ltd, Taipei, Taiwan) via single oral administration. 24 mice were used and randomized into 4 groups, each consisting of six males. The treated mice were administered with **T1** at dose levels of 1500, 3000, and 6000 mg/kg, and the control mice were administered with vehicle control (4% Tween 80 in water for injection (Brand: SIGMA, Lot No.: 44H01211) was used for vehicle control and dosing solution preparation). The dosing volume of 20 ml/kg was adjusted according to the individual body weight recorded prior to dosing. The mice were observed for clinical signs and mortality for 14 days at 0, 1, 2, 3, and 4 hours after dosing. The observations for the mortality (twice daily, at least six hours apart) and clinical signs (once a day) were conducted from SD3 to SD14. All clinical signs were recorded. Body weight records were made on all animals before the start of dosing (SD1), after seven days interval (SD8) and on the final day of the study (SD15). All surviving mice were subjected to gross necropsy at the end of study (SD15). The surviving mice were further exsanguinated and necropsied in the thoracic and abdominal cavities for clinical check under euthanized condition. All experiments were approved by the Animal Care and the Use Committees of Center of Toxicology and Preclinical Sciences, the Development Center for Biotechnology (Approval FR-AC00266E).

Molecular Modeling
------------------

Models of the compound **T1**, **T2**, **T3**, and **T5** in complex with tyrosinase were generated through molecular docking analysis. In order to predict the positions of **T1**, **T2**, **T3**, and **T5** in the active site, we implemented a docking program (GOLD Genetic Optimization for Ligand Docking) (Cambridge Crystallographic Data Center (CCDC), version 5.2) with the Goldscore scoring function. Before docking, the cofactors and all water molecules were removed. The 3D structure of the compound **T1**, **T2**, **T3**, and **T5** were generated and optimized by energy minimization using *Discovery Studio v.4.0* (Accelrys Software Inc., USA). GOLD was used to dock **T1**, **T2**, **T3**, and **T5** into the active site of the X-ray (PDB ID: 2Y9X) and a human tyrosinase model (built by Multiple sequences alignment and Homology modeling of *Discovery Studio v.4.0* using the structure of mushroom tyrosinase as a template (PDB ID: 2Y9X) ([Supplementary Fig. S1](#s1){ref-type="supplementary-material"})) with the flexible docking option turned on. To comprehensively examine the docking conformational space, the search efficiency was set at 100%. All other parameters were set as default. Finally, from the 100 docking conformations, the top one with the highest GOLD fitness score was chosen to explore the binding mode of docked compound in the mushroom tyrosinase active site using Goldscore within the GOLD program. The molecular models of the docked compound were displayed using the PyMOL software. (<http://www.pymol.org>).

Results
=======

Tyrosinase inhibitory potency of T1 and its derivative compounds
----------------------------------------------------------------

Mushroom tyrosinase has been extensively applied for the estimation and characterization of potential tyrosinase inhibitors[@b70]. Our group extracted 400 natural compounds from 78 known Chinese herbal plants, and the preliminary tyrosinase inhibition test showed that second natural components, **T1** and **T2**, isolated from *Gastrodia elata* exhibit apparent tyrosinase inhibitory ability. **T2**, **T3**, **T4** and **T5** are **T1** derivative compounds. Therefore, we further quantified their inhibitory capacity in IC~50~ for comparison with those of the reference inhibitors, β-arbutin and kojic acid ([Fig. 1](#f1){ref-type="fig"}). The result shows that the natural compound **T2** exhibits equivalent inhibitory ability to that of β-arbutin, and **T4** shows less potent tyrosinase inhibitory potency (IC~50~ \> 2400 μM). On the other hand, the compounds **T3** and **T5** display stronger tyrosinase inhibitory abilities than β-arbutin, and the natural compound **T1** (IC~50~ = 0.53 μM) exhibits the greatest inhibitory potency among all, even superior to kojic acid (IC~50~ = 40.69 μM). Moreover, a Dixon plot is used to determine the enzyme-inhibitor inhibition constant (*Ki*). The *Ki* value for **T1** against mushroom tyrosinase is 58 ± 6 nM ([Supplementary Fig. S2](#s1){ref-type="supplementary-material"}), indicating that T1 is a strong competitive inhibitor and is comparable with those have been reported tyrosinase inhibitors[@b71].

Cell viability and Melanin quantification assay
-----------------------------------------------

The inhibitory effect of **T1** on human melanin formation was investigated. The change of melanin content in the normal human melanocyte cells treated with 5 μM and 50 μM of **T1** was examined individually to determine the depigmentation activity. The result shows that only 50 μM of **T1** sufficiently attenuate 20% melanin content ([Fig. 2b](#f2){ref-type="fig"}), whereas there is little or no decrease of the melanin content at the presence of 50 μM of α- and β-arbutin and kojic. Moreover, to evaluate the cytotoxic effect of **T1**, MTT assay was applied to investigating whether the **T1** compound would induce cell death adversely. The effect of **T1** on cell viability was shown in [Fig. 2a](#f2){ref-type="fig"}. At a dose of 5 and 50 μM of **T1**, cell viability is 99.2% and 97.2% respectively, almost identical to those of α- and β-arbutin and kojic. Thus, it is believed that **T1** is non-cytotoxic to normal human melanocyte cells in the concentration ranging from 0 to 50 μM.

Zebrafish (in vivo assay)
-------------------------

In addition to estimating the effects of T1 on cell viability and human melanogenesis, we further evaluate its anti-pigmentation ability through *in vivo*. Zebrafish is an particularly useful vertebrate model organism because it possesses similar gene sequences and organ systems to human beings[@b72]. With these advantages, the zebrafish system was employed to investigate the *in vivo* melanogenic inhibition[@b68], and the compound toxicity was also determined simultaneously. The inhibition effects of **T1** on the pigmentation of zebrafish were evaluated. Arbutin and kojic acid were used as control groups. With the treatment of 50 μM **T1**, the pigmentation level of zebrafish obviously decreases about 41.4% ([Fig. 3b](#f3){ref-type="fig"}). However, the de-pigmenting effects at the presence of 0.1, 1, and 10 mM of β-arbutin are individually much lower than that of 50 μM **T1**. Additionally, **T1** also shows a better de-pigmenting effect than kojic acid---at 50 μM, kojic acid decreases 12.9% pigmentation level, while **T1** can decrease 3-fold of that (41.4%), as shown in [Fig. 3b](#f3){ref-type="fig"}.

Acute oral toxicity assay in mice
---------------------------------

An acute oral toxicity study was performed to examine the toxicity of **T1** in ICR male mice via single oral administration. 24 mice were used and randomized into 4 groups, each consisting of 6 mice. There was no death and abnormal clinical symptom observed in any subject, which lived up to 14 days after the administrations of the **T1** compound at the dosage levels of 1500, 3000, and 6000 mg/kg body weight ([Fig. 4](#f4){ref-type="fig"}). The mean body weight and mean body weight gain in mice were calculated, as presented in [Fig. 1](#f1){ref-type="fig"}. The mean body weight growth curves are shown in [Fig. 5](#f5){ref-type="fig"}. There is no difference in body weight as well as body gain observed among **T1**-treated and control mice, and no observable gross lesion was found.

Molecular docking analysis
--------------------------

GOLD molecular docking analysis was applied to investigate the binding interactions of **T1, T2, T3 and T5** molecules, respectively with mushroom tyrosinase to elucidate the possible molecular mechanism. In our docking model, the sulfur atom of **T1** makes close contacts with the copper ions of tyrosinase ([Fig. 5a and c](#f5){ref-type="fig"}). In addition, two hydrogen bonds were observed between the hydroxyl groups of **T1** and Asn260 and His224, respectively. The side chains of residues Glu256, Phe90, Val238, and Phe264 show tightly hydrophobic contacts and/or π-π interactions with the **T1** molecule. The molecular docking results of **T2**, **T3** and **T5** will be compared and discussed in discussion.

Discussion
==========

The inhibition of tyrosinase, decreasing of melanocyte metabolism and avoiding of UV exposure are ways to reduce melanin synthesis. Among these, tyrosinase inhibitors are of great treatment for pigmentation and developed as cosmetically skin-whitening agents[@b22][@b31][@b70][@b73]. In this study, for the purpose of developing a safe and effective skin-whitening agent, we screened about 400 natural products from 78 different of Chinese herbal plants for compounds with inhibitory activity against mushroom tyrosinase. The natural compound **T1** isolated from *Gastrodia elata* shows outstanding inhibitory potency against tyrosinase (IC~50~ = 0.53 μM, *K*i = 58 ± 6 nM), which is more effective than β-arbutin, kojic acid, short peptides[@b74][@b75] and other known natural compounds ([Supplementary Table S1](#s1){ref-type="supplementary-material"}). Our docking model demonstrates that the sulfur atom of **T1** makes close contacts with the copper ions in the active site of tyrosinase ([Fig. 5a and c](#f5){ref-type="fig"}), implying that **T1** may function as a copper chelator to abolish the tyrosinase activity and this can be evident by our inhibition assay result--**T1** is a strong competitive inhibitor of mushroom tyrosinase ([Supplementary Fig. S2](#s1){ref-type="supplementary-material"}). However, the natural product **T2**, with a replacement of the sulfur atom of **T1** by an oxygen atom, shows 713-fold decrease in the inhibitory ability (IC~50~ = 378.11 μM). The docking model shows that **T2** applies distinct orientation to interact with the active site residues of mushroom tyrosinase--its hydroxyl group of one benzene ring but not the oxygen atom makes close contacts with one copper ion ([Fig. 5b and d](#f5){ref-type="fig"}). This indicates that the sulfur atom of **T1** is of great potential in interacting with copper ions than the oxygen atom of **T2** and significant contributes in mushroom tyrosinase inhibition. On the other hand, shortening of the carbon linker which connects the sulfur atom to benzene rings results in the moderate tyrosinase inhibition of **T3** (IC~50~ = 102.35 μM), demonstrating the significance of the degree of freedom of the sulfur atom and benzene rings in tyrosinase inhibition ([Supplementary Fig. S3a](#s1){ref-type="supplementary-material"}). In addition, the removal of the hydroxyl groups of **T1** (corresponding to **T4** molecule) leads to poor tyrosinase inhibition (IC~50~ \> 2400 μM), indicating that the two hydroxyl groups which contribute to the hydrogen bond interactions with Asn260 and His224 ([Fig. 5a and c](#f5){ref-type="fig"}) make extensive contributions to the inhibition ability. Finally, **T5**, analogous to **T1** where hydroxyl groups are substituted by methoxy groups, results in an IC~50~ = 40.02 μM, suggesting that hydrogen bonds (provided by the hydroxyl groups) are more favorable than the hydrophobic interactions (supported by the methoxy groups) in mushroom tyrosinase inhibition ([Supplementary Fig. S3b](#s1){ref-type="supplementary-material"}).

For the purpose of finding an effective and safe whiting substance which can be applied for preventing human hyperpigmentation, the natural product **T1** is of great candidacy for evaluating its cell viability and inhibition of melanogenesis. Treatments (5 and 50 μM) of **T1** do not show significant cytotoxicity to human normal melanocytes, making it superior to arbutin and kojic acid ([Fig. 2](#f2){ref-type="fig"}). In the human melanocyte system, we also found that melanin production levels apparently decrease by about 20% when treated with 50 μM of **T1**; however, there is very few or no melanin content decrease observed in the treatment with 50 μM α- and β-arbutin and kojic acid. These results demonstrate that the natural compound **T1**, taken from the herbal medicine source (*Gastrodia elata*), apparently attenuates melanogenesis without significant cytotoxicity. This result indicates that the reduced melanin production is not attributable to the cytotoxicity of **T1**, and **T1** can be a safe skin-lightening agent without influencing melanocyte growth. In addition, the molecular docking analysis shows that **T1** adapts the same orientation as interacting with mushroom tyrosinase to interact with human tyrosinase ([Supplementary Fig. S4](#s1){ref-type="supplementary-material"}). However, the mainly difference is that the hydrophobic and hydrogen-bonding interactions contributed by the active site residues, H244, E256 and F264 in mushroom tyrosinase are not observed in the corresponding active site residues, P505, S515, and I523 of human tyrosinase ([Supplementary Fig. S1](#s1){ref-type="supplementary-material"}). This indicates that **T1** may be more specific to mushroom instead of human tyrosinase, giving an explanation of **T1** significantly inhibits the activity of mushroom tyrosinase but is not highly efficient on reducing human melanin production.

The melanin content of **T1**-treated zebrafish was investigated. The substantially reduces of skin melanin content in the developed larvae are observed in the T1 treated (between 9--57 hpf, total 48 h exposure) embryos. At the same concentration (50 μM), **T1** causes a higher degree of transparency (reducing around 41.4% of pigmentation production) than those seen in β-arbutin and kojic acid, indicating that the de-pigmenting effect of **T1** is far more efficient than those of the high dose-dependent β-arbutin and kojic acid ([Fig. 3](#f3){ref-type="fig"}). This result reveals that the **T1** compound effectively reduces melanogenesis in zebrafish and is comparable with the melanin quantification in melanocytes.

As a desirable depigmenting agent, the natural compound **T1** is highly safe and without any side effect. Acute oral toxicity test was carried out in the present study to evaluate the safety of **T1**. Throughout the 14 days of observation after oral administration, there were no deaths and clinical abnormal changes observed in the treated mice, which were dosed at 1500, 3000, 6000 mg of the **T1** compound per kilogram of body weight. These treated mice did not show any signs of toxicity, and the overall conditions of these mice were similar to that of the control ones. The toxicologically considerable changes in mean body weight were not observed in the animals treated with **T1** ([Supplementary Table S2](#s1){ref-type="supplementary-material"} and [Fig. 4](#f4){ref-type="fig"}). Thus, **T1** exerted no adverse toxic effects in ICR mice at a dose up to 6000 mg/kg. The result of this study will be served as a reference of safety margin for human use.

Conclusion
==========

This study screened 78 different Chinese herbal plants and identified the potent and functional components useful for tyrosinase inhibition, melanogenic inhibition, and depigmentation. The natural component **T1**, isolated from *Gastrodia elata*, is a strong competitive inhibitor of mushroom tyrosinase (IC~50~ = 0.53 μM, *K*i = 58 ± 6 nM), which is superior to kojic acid (IC~50~ = 40.69 μM) and more effective than other known natural products. The *in vitro* assay demonstrates that 50 μM of **T1** apparently attenuates 20% melanin content of human normal melanocytes and shows no significant cell toxicity. The *in vivo* assay reveals that **T1** effectively reduces melanogenesis in zebrafish without any adverse side effects. The acute oral toxicity study evidently confirms that the **T1** molecule is free of discernable cytotoxicity in mice. The molecular models reveals that the sulfur atom of **T1** interacting with the copper ions in the active site of tyrosinase is crucial for mushroom tyrosinase inhibition and the ability of disturbing the human melanin synthesis. In conclusion, **T1** isolated from *Gastrodia elata* is a potential candidate in developing safe cosmetic and pharmacological agents, which is of great potency in skin-whitening.
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![Comparison of mushroom tyrosinase inhibitory abilities (IC~50~) among kojic acid, arbutin, natural product T1 and its derivative T2--T5.\
(a) The IC~50~ values of β-arbutin, kojic acid, natural product **T1** and its derivative **T2--T5**. (b) 2D chemical structure of natural product **T1** and its derivative **T2--T5**.](srep07995-f1){#f1}

![The effects of arbutin, kojic acid, and T1 on cell viability and melanogenesis of human melanocyte.\
(a) The cell viability under the individual treatment of arbutin, kojic acid, and **T1** determined with 5 μM and 50 μM by MTT assay. (b) The melanin contents of arbutin, kojic acid, and **T1** treated human melanocytes with 50 μM. DMSO indicates buffer control. \*\*\**P* \< 0.001 versus DMSO control.](srep07995-f2){#f2}

![Estimation and comparison of depigmenting effects of β-arbutin, kojic acid and T1 by *in vivo* zebrafish assay.\
(a) Illustration of the pigmentation levels of zebrafish treated with **T1** (50 μM) and β-arbutin (0.1 mM, 1 mM, and 10 mM). (b) Comparison of the depigmenting effects of kojic acid and **T1** at 10, 25, 40, and 50 μM. KA represents Kojic acid.](srep07995-f3){#f3}

![The mean body weight growth curves of T1-treated mice in the acute oral toxicity study.\
Body weight of all mice treated with **T1** was recorded at the start of dosing (SD 1), weekly interval (SD 8), and the end of the study period (SD 15).](srep07995-f4){#f4}

![Molecular docking analyses of T1 and T2 toward mushroom tyrosinase.\
(a) The docking model of **T1** molecule in the active site of mushroom tyrosinase. **T1** molecule is colored in cyan, and residues interacting with **T1** are colored in white and orange (6 histidine residues). (b) The docked **T2** molecule (colored in green) interacts with the active site residues (colored in white and orange) of mushroom tyrosinase. (c) 2D schematic representation of the interactions between **T1** and active site residues of mushroom tyrosinase. (d) 2D schematic representation of the interactions between **T2** and active site residues of mushroom tyrosinase. (The green dash lines in a and b panels donate the hydrogen bond interactions, the yellow ones represent the hydrophobic interactions, and the red spheres represent two cooper ions. In 2D schemes, green dash line denotes hydrogen bond interaction; circles in distinct colors represent the relative hydrophobic and/or π-π interactions).](srep07995-f5){#f5}
